Related Experiment Video

Updated: May 2, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

1.4K

Pneumonitis due to cytomegalovirus during chronic methotrexate treatment

Marco Aurelio Ramírez Huaranga1, Erika Bencosme de Mendez2, José Luis Cuadra Díaz1

  • 1Servicio de Reumatología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.

Reumatologia Clinica
|March 21, 2014
PubMed

Insights

Methotrexate treatment can cause lung issues beyond hypersensitivity pneumonitis, including infections like Cytomegalovirus pneumonia. Early diagnosis and treatment are crucial for managing these serious respiratory complications.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Oncology

Background:

  • Methotrexate is a common medication used in treating various autoimmune diseases and cancers.
  • Pulmonary complications are known side effects of methotrexate therapy.
  • Hypersensitivity pneumonitis is the most frequently reported lung complication.

Observation:

  • This study considers other potential respiratory complications associated with methotrexate.
  • Lymphoproliferative disorders and infectious diseases are noted as important considerations.
  • An increased risk of infections, similar to that seen with TNF antagonists and corticosteroids, is highlighted.

Findings:

  • Cytomegalovirus (CMV) pneumonia is identified as a serious potential complication.
  • The risk of infectious diseases warrants attention in patients on methotrexate.
  • Prompt diagnosis and intervention are essential for patient outcomes.

Implications:

  • Clinicians should consider a broader spectrum of pulmonary complications beyond hypersensitivity pneumonitis in methotrexate users.
  • Vigilance for infectious etiologies, particularly CMV pneumonia, is necessary.
  • Timely management can prevent severe morbidity and mortality associated with these methotrexate-induced respiratory issues.
Keywords:
CitomegalovirusCytomegalovirusMethotrexateMetotrexatoNeumonitis

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.0K
Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

14.3K

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K